EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID ‐exacerbated respiratory disease

Franziska Hartung iD, Pascal Haimerl, Sonja Schindela, Veronika Mussack, Benedikt Kirchner, Fiona D R Henkel, Ulrike Bernhardt, Ulrich M Zissler iD, Rachel Santarella-Mellwig, Michael Pfaffl iD, Carsten B Schmidt-Weber iD, Adam M Chaker iD and 1 more

Allergy · 2024-07 · 79 (7) · 1893-1907

DOI: 10.1111/all.16117 ↗

At a glance

Journal article in Allergy, published online on 2024-04-04. Written by Franziska Hartung and 12 co-authors. Institution: Center of Allergy and Environment (ZAUM), Technical University of Munich and Helmholtz Center Munich, Munich, Germany. Major MEDLINE topics: Extracellular Vesicles, MicroRNAs, Macrophages, Anti-Inflammatory Agents, Non-Steroidal. Cited 16 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Helmholtz Initiative and Networking, Deutsche Forschungsgemeinschaft, Else Kröner-Fresenius-Stiftung.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Extracellular vesicles (EVs) have been implicated in the pathogenesis of asthma, however, how EVs contribute to immune dysfunction and type 2 airway inflammation remains incompletely understood. We aimed to elucidate roles of airway EVs and their miRNA cargo in the pathogenesis of NSAID‐exacerbated respiratory disease (N‐ERD), a severe type 2 inflammatory condition.

Methods

EVs were isolated from induced sputum or supernatants of cultured nasal polyp or turbinate tissues of N‐ERD patients or healthy controls by size‐exclusion chromatography and characterized by particle tracking, electron microscopy and miRNA sequencing. Functional effects of EV miRNAs on gene expression and mediator release by human macrophages or normal human bronchial epithelial cells (NHBEs) were studied by RNA sequencing, LC–MS/MS and multiplex cytokine assays.

Results

EVs were highly abundant in secretions from the upper and lower airways of N‐ERD patients. N‐ERD airway EVs displayed profoundly altered immunostimulatory capacities and miRNA profiles compared to airway EVs of healthy individuals. Airway EVs of N‐ERD patients, but not of healthy individuals induced inflammatory cytokine (GM‐CSF and IL‐8) production by NHBEs. In macrophages, N‐ERD airway EVs exhibited an impaired potential to induce cytokine and prostanoid production, while enhancing M2 macrophage activation. Let‐7 family miRNAs were highly enriched in sputum EVs from N‐ERD patients and mimicked suppressive effects of N‐ERD EVs on macrophage activation.

Conclusion

Aberrant airway EV miRNA profiles may contribute to immune dysfunction and chronic type 2 inflammation in N‐ERD. Let‐7 family miRNAs represent targets for correcting aberrant macrophage activation and mediator responses in N‐ERD.

Subjects

MeSH terms (MEDLINE)

Extracellular VesiclesMicroRNAsMacrophagesAnti-Inflammatory Agents, Non-SteroidalHumansCytokinesMaleFemaleMiddle AgedMacrophage ActivationAdult

Author keywords

CRSwNPasthmaextracellular vesiclesmacrophagestype 2 immunity

Substances

MicroRNAsAnti-Inflammatory Agents, Non-SteroidalCytokines

Authors and institutions

  • Center of Allergy and Environment (ZAUM), Technical University of Munich and Helmholtz Center Munich, Munich, Germany.
  • Division of Animal Physiology and Immunology, Technical University of Munich, Freising, Germany.
  • Member of the German Center of Lung Research (DZL), Munich, Germany.
  • EMBL Heidelberg, Heidelberg, Germany.
  • Department of Otorhinolaryngology and Head and Neck Surgery, TUM School of Medicine and Health, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Department of Immunobiology, University of Lausanne, Epalinges, Switzerland.

ORCID profiles: Franziska Hartung, Ulrich M Zissler, Michael Pfaffl, Carsten B Schmidt-Weber, Adam M Chaker, Julia Esser-von Bieren

Funding

  • Helmholtz Initiative and Networking
  • Deutsche Forschungsgemeinschaft
  • Else Kröner-Fresenius-Stiftung

Cite

APA

Hartung, F., Haimerl, P., Schindela, S., Mussack, V., Kirchner, B., Henkel, F. D. R., Bernhardt, U., Zissler, U. M., Santarella-Mellwig, R., Pfaffl, M., Schmidt-Weber, C. B., Chaker, A. M., & Esser-von Bieren, J. (2024). Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID ‐exacerbated respiratory disease. Allergy, 79(7), 1893-1907. https://doi.org/10.1111/all.16117

Vancouver

Hartung F, Haimerl P, Schindela S, Mussack V, Kirchner B, Henkel FDR, et al. Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID ‐exacerbated respiratory disease. Allergy. 2024;79(7):1893-1907. doi:10.1111/all.16117

BibTeX
@article{Hartung2024,
  author = {Hartung, Franziska and Haimerl, Pascal and Schindela, Sonja and Mussack, Veronika and Kirchner, Benedikt and Henkel, Fiona D R and Bernhardt, Ulrike and Zissler, Ulrich M and Santarella-Mellwig, Rachel and Pfaffl, Michael and Schmidt-Weber, Carsten B and Chaker, Adam M and Esser-von Bieren, Julia},
  title = {Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID ‐exacerbated respiratory disease},
  journal = {Allergy},
  year = {2024},
  volume = {79},
  number = {7},
  pages = {1893--1907},
  doi = {10.1111/all.16117}
}
Start for free →